Is it necessary to re-evaluate diagnostic criteria for Wilson disease in children?

Oya Balcı Sezer1, Peren Perk, Ferda Özbay Hoşnut

  • 1Department of Pediatric Gastroenterology, Başkent University Faculty of Medicine, Ankara, Turkey. oyabalci@yahoo.com.

Insights

Diagnosing Wilson Disease (WD) in children is difficult. This study establishes new liver and urine copper cut-off values to better differentiate WD from other pediatric liver diseases.

Area of Science:

  • Pediatric Hepatology
  • Medical Diagnostics
  • Trace Element Metabolism

Background:

  • Wilson Disease (WD) diagnosis in children is challenging due to overlapping symptoms with other chronic liver diseases.
  • Elevated liver copper levels can occur in conditions beyond WD, complicating differential diagnosis.
  • Accurate diagnostic markers are crucial for timely WD treatment in pediatric populations.

Purpose of the Study:

  • To establish specific liver and 24-hour urinary copper cut-off values for differentiating Wilson Disease (WD) in children.
  • To compare these novel cut-off values against existing diagnostic criteria.
  • To improve the diagnostic accuracy of WD in pediatric patients with chronic liver disease.

Main Methods:

  • Analyzed data from 76 pediatric patients (35 WD, 41 non-WD).
  • Measured liver and 24-hour urinary copper levels using atomic absorption spectrometry.
  • Employed Receiver Operating Characteristic (ROC) analysis to determine optimal diagnostic cut-off values.

Main Results:

  • A liver copper cut-off of 98 µg/g showed 91% sensitivity and 65.4% specificity for WD.
  • A 24-hour urinary copper cut-off of 67.5 µg/24h demonstrated 85% sensitivity and 71% specificity for WD.
  • Both cut-offs provided significant diagnostic capability (AUC > 0.83).

Conclusions:

  • Established liver and urinary copper cut-off values differ from current diagnostic standards for pediatric WD.
  • The findings suggest a need for revised diagnostic thresholds for WD in children.
  • Further large-scale studies are recommended to validate these pediatric-specific copper cut-offs.
Abstract

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
266
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
378
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.8K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.1K
Diabetes Insipidus I: Introduction01:29

Diabetes Insipidus I: Introduction

Definition Diabetes insipidus is a disorder marked by the production of large amounts of dilute urine because of impaired vasopressin production, release, or kidney response. The lack of effective vasopressin action limits water reabsorption in the renal collecting ducts, which leads to excessive urinary water loss and intense thirst.Clinical PresentationIndividuals with diabetes insipidus report persistent thirst and very high urine output. In severe cases, fluid intake can reach up to 20...
6
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated...
4